Question 1

What are the most cited papers from Middlemore Clinical Trials?

Accepted Answer

The most cited paper from Middlemore Clinical Trials is "Azithromycin for prevention of exacerbations in non-cystic fibrosis bronchiectasis (EMBRACE): a randomised, double-blind, placebo-controlled trial" (Conroy Wong, Lata Jayaram, Noel Karalus et al., 2012), with 604 citations. Next come "Reduction of dietary sodium to less than 100 mmol in heart failure (SODIUM-HF): an international, open-label, randomised, controlled trial" (182) and "Effect of Low-Sodium versus Conventional Sodium Dialysate on Left Ventricular Mass in Home and Self-Care Satellite Facility Hemodialysis Patients: A Randomized Clinical Trial" (45).

Question 2

Which research topics does Middlemore Clinical Trials publish most on?

Accepted Answer

By volume in 2022-now: Diabetes Treatment and Management, Medication Adherence and Compliance, Global Public Health Policies and Epidemiology and Diabetes Management and Education.

Question 3

Which fields of science does Middlemore Clinical Trials work in?

Accepted Answer

In all years, 83% of research at Middlemore Clinical Trials is in Health Sciences, 12% in Life Sciences. Its largest fields are Medicine (79%), Biochemistry, Genetics and Molecular Biology (12%), Health Professions (5%). It does 1.6× the world's share of Health Sciences.

Question 4

Is Middlemore Clinical Trials's research output growing?

Accepted Answer

Output in 2022-2025 was 69% lower than in 2018-2021.